EE355 The Budgetary Consequences of Increasing Utilization of Dronedarone Relative to Other Antiarrythmic Drugs to a Hypothetical U.S. Payer

Autor:	J Ken-Opurum, P Vadagam, L Faith, SSS Srinivas, S Park, S Charland, A Revel
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S404
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.04.603
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4051644af1bbe2950e4fa967e0f686c5 https://doi.org/10.1016/j.jval.2022.04.603 Zobrazit plný text záznamu Full Text from ScienceDirect